Neuromuscular
Clinical Research
If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@CUAnschutz.edu
| COMIRB # | Study Title | Principal Investigator | Eligibility and Information | IRB Approved Advertisement |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | ||||
| 19-1560 | Radicava/Edaravone Findings in Biomarkers From ALS (REFINE-ALS) | Laura Foster, MD | Clinical Trials | Trial Website |
| 19-2645 | Healey ALS Platform Trial | Laura Foster, MD | Clinical Trials | Platform Video |
| 20-0127 | Clinical Procedures To Support Research (CAPTURE ALS) | Laura Foster, MD | Clinical Trials | Trial Website |
| 20-2005 | MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults with ALS | Dianna Quan, MD | Clinical Trials | Trial Website |
| 20-2340 | A Phase 3b, Multicenter, Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Oral Edaravone | Stacy Dixon, MD, PhD | Clinical Trials | N/A |
| 21-2598 | COURAGE-ALS: Phase 3, double-blind, randomized, placebo-controlled trial of reldesemtiv in patients aged 18 to 80 with ALS | Dianna Quan, MD | Clinical Trials | N/A |
Charcot Marie Tooth Disease | ||||
| 18-2537 | Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601) | Vera Fridman, MD | Clinical Trials | N/A |
| 20-1525 | Genetics of CMT – Modifiers of CMT1A, New Causes of CMT (INC-6602) | Vera Fridman, MD | Clinical Trials | N/A |
Facioscapulohumeral Muscular Dystrophy | ||||
| 20-0405 | Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Inclusion Body Myositis | ||||
| 17-1132 | Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study | Matthew Wicklund, MD | Clinical Trials | N/A |
| Limb Girdle Muscular Dystrophy | ||||
| 19-2943 | Biomarker Development in LGMD 2i (MLB-01-001) | Matthew Wicklund, MD | Clinical Trials | N/A |
| 19-0506 | Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (GRASP) | Matthew Wicklund, MD | Clinical Trials | N/A |
| Myasthenia Gravis | ||||
| 20-0609 | A Study of TAK-079 in People with Generalized Myasthenia Gravis | Thomas Ragole, MD | Clinical Trials | N/A |
| 20-1787 | Myasthenia Gravis Inebilizumab Trial (MINT) | Dianna Quan, MD | Clinical Trials | N/A |
| 21-3289 | VIVACITY-MG: A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Dianna Quan, MD | Clinical Trials | N/A |
| TTR Amyloidosis | ||||
| 08-0623 | Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis | Dianna Quan, MD | Clinical Trials | N/A |